日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis

高剂量化疗作为复发或难治性生殖细胞癌患者一线或后续挽救治疗的疗效和安全性:一项国际多中心分析

Seidel, C; Schaefers, C; Connolly, E A; Weickhardt, A; Grimison, P; Wong, V; De Giorgi, U; Hentrich, M; Zschäbitz, S; Ochsenreither, S; Vincenzi, B; Oing, C; Bokemeyer, C; Engel, N; Alsdorf, W; Tran, B

Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

血液病和肿瘤门诊患者对SARS-CoV-2疫苗初次接种和加强接种体液免疫反应不良的危险因素——COVIDOUT研究

Schönlein, Martin; Wrage, Victoria; Ghandili, Susanne; Mellinghoff, Sibylle C; Brehm, Thomas Theo; Leypoldt, Lisa B; Utz, Nils; Schrader, Roland M; Alsdorf, Winfried; Börschel, Niklas; Bußmann, Lara; Schönrock, Martin; Perlick, Dorothea; Schön, Gerhard; Verpoort, Karl; Lütgehetmann, Marc; Schulze Zur Wiesch, Julian; Weisel, Katja C; Bokemeyer, Carsten; Schafhausen, Philippe; Sinn, Marianne

Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation

一项针对接受高强度化疗免疫疗法和自体干细胞移植治疗的继发性中枢神经系统淋巴瘤患者的真实世界队列研究结果

Thiele, Benjamin; Binder, Mascha; Schliffke, Simon; Frenzel, Christian; Dierlamm, Judith; Wass, Maxi; Weisel, Katja C; Bokemeyer, Carsten; Janjetovic, Snjezana

Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML

新诊断和复发性 AML 患者中 TIGIT+CD73-CD8+ T 细胞(TOX+ TCF-1low 型)频率增加

F Brauneck, F Haag, R Woost, N Wildner, E Tolosa, A Rissiek, G Vohwinkel, J Wellbrock, C Bokemeyer, J Schulze Zur Wiesch, C Ackermann, W Fiedler

Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

肥大细胞通过分泌基质降解颗粒酶 B 降低抗血管生成治疗的疗效

M Wroblewski, R Bauer, M Cubas Córdova, F Udonta, I Ben-Batalla, K Legler, C Hauser, J Egberts, M Janning, J Velthaus, C Schulze, K Pantel, C Bokemeyer, S Loges

Mutational landscape reflects the biological continuum of plasma cell dyscrasias

突变图谱反映了浆细胞疾病的生物学连续谱

Rossi, A; Voigtlaender, M; Janjetovic, S; Thiele, B; Alawi, M; März, M; Brandt, A; Hansen, T; Radloff, J; Schön, G; Hegenbart, U; Schönland, S; Langer, C; Bokemeyer, C; Binder, M

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

生长停滞特异性基因 6-Mer 轴在多发性骨髓瘤中的作用

J S Waizenegger, I Ben-Batalla, N Weinhold, T Meissner, M Wroblewski, M Janning, K Riecken, M Binder, D Atanackovic, H Taipaleenmaeki, D Schewe, S Sawall, V Gensch, M Cubas-Cordova, A Seckinger, W Fiedler, E Hesse, N Kröger, B Fehse, D Hose, B Klein, M S Raab, K Pantel, C Bokemeyer, S Loges

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients

趋化因子 CXCL13 在乳腺癌患者的肿瘤组织和外周血中过度表达

J Panse, K Friedrichs, A Marx, Y Hildebrandt, T Luetkens, K Barrels, C Horn, T Stahl, Y Cao, K Milde-Langosch, A Niendorf, N Kröger, S Wenzel, R Leuwer, C Bokemeyer, S Hegewisch-Becker, D Atanackovic

Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis

成人睾丸生殖细胞肿瘤中的限制性 12p 扩增和 RAS 突变

H Roelofs, M C Mostert, K Pompe, G Zafarana, M van Oorschot, R J van Gurp, A J Gillis, H Stoop, B Beverloo, J W Oosterhuis, C Bokemeyer, L H Looijenga

Endocrinological late effects after chemotherapy for testicular cancer

睾丸癌化疗后的内分泌远期效应

Berger, C C; Bokemeyer, C; Schuppert, F; Schmoll, H J